nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC2—Spironolactone—dilated cardiomyopathy	0.217	0.347	CbGbCtD
Lamivudine—ABCC2—Furosemide—dilated cardiomyopathy	0.149	0.237	CbGbCtD
Lamivudine—SLC22A6—Furosemide—dilated cardiomyopathy	0.109	0.174	CbGbCtD
Lamivudine—ABCB1—Lisinopril—dilated cardiomyopathy	0.0805	0.129	CbGbCtD
Lamivudine—ABCB1—Spironolactone—dilated cardiomyopathy	0.0709	0.113	CbGbCtD
Lamivudine—Breath sounds abnormal—Lisinopril—dilated cardiomyopathy	0.0073	0.0386	CcSEcCtD
Lamivudine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.00529	0.028	CcSEcCtD
Lamivudine—Skin infection—Lisinopril—dilated cardiomyopathy	0.00463	0.0245	CcSEcCtD
Lamivudine—NT5C—heart—dilated cardiomyopathy	0.00421	0.122	CbGeAlD
Lamivudine—PCYT1A—heart—dilated cardiomyopathy	0.00395	0.114	CbGeAlD
Lamivudine—CMPK1—cardiac ventricle—dilated cardiomyopathy	0.00387	0.112	CbGeAlD
Lamivudine—CMPK1—myocardium—dilated cardiomyopathy	0.00364	0.105	CbGeAlD
Lamivudine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00351	0.0186	CcSEcCtD
Lamivudine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00307	0.0162	CcSEcCtD
Lamivudine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00298	0.0198	CbGpPWpGaD
Lamivudine—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00285	0.0151	CcSEcCtD
Lamivudine—NME1—heart—dilated cardiomyopathy	0.00264	0.0764	CbGeAlD
Lamivudine—CMPK1—heart—dilated cardiomyopathy	0.00254	0.0736	CbGeAlD
Lamivudine—NME2—heart—dilated cardiomyopathy	0.00249	0.072	CbGeAlD
Lamivudine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00224	0.0119	CcSEcCtD
Lamivudine—CMPK1—cardiac atrium—dilated cardiomyopathy	0.00218	0.063	CbGeAlD
Lamivudine—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.00207	0.011	CcSEcCtD
Lamivudine—Drug interaction—Furosemide—dilated cardiomyopathy	0.00201	0.0106	CcSEcCtD
Lamivudine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00196	0.0104	CcSEcCtD
Lamivudine—Throat sore—Lisinopril—dilated cardiomyopathy	0.00194	0.0103	CcSEcCtD
Lamivudine—ABCC3—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00193	0.0128	CbGpPWpGaD
Lamivudine—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00192	0.0102	CcSEcCtD
Lamivudine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00191	0.0101	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0019	0.0101	CcSEcCtD
Lamivudine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00188	0.00998	CcSEcCtD
Lamivudine—ABCC4—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00182	0.0121	CbGpPWpGaD
Lamivudine—DCK—myocardium—dilated cardiomyopathy	0.00181	0.0525	CbGeAlD
Lamivudine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00179	0.00947	CcSEcCtD
Lamivudine—NT5C—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00178	0.0118	CbGpPWpGaD
Lamivudine—CMPK1—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00178	0.0118	CbGpPWpGaD
Lamivudine—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00175	0.00927	CcSEcCtD
Lamivudine—NME1—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.00175	0.0116	CbGpPWpGaD
Lamivudine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00173	0.00914	CcSEcCtD
Lamivudine—Urine output increased—Furosemide—dilated cardiomyopathy	0.00169	0.00893	CcSEcCtD
Lamivudine—NME1—Arf6 trafficking events—ADRB2—dilated cardiomyopathy	0.00166	0.011	CbGpPWpGaD
Lamivudine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00163	0.00862	CcSEcCtD
Lamivudine—NME1—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.0016	0.0106	CbGpPWpGaD
Lamivudine—NME1—E-cadherin signaling in the nascent adherens junction—RAC1—dilated cardiomyopathy	0.0016	0.0106	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00157	0.0105	CbGpPWpGaD
Lamivudine—Viral infection—Lisinopril—dilated cardiomyopathy	0.00155	0.0082	CcSEcCtD
Lamivudine—Polyuria—Furosemide—dilated cardiomyopathy	0.00154	0.00816	CcSEcCtD
Lamivudine—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00154	0.00815	CcSEcCtD
Lamivudine—ABCC2—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00153	0.0102	CbGpPWpGaD
Lamivudine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00152	0.00805	CcSEcCtD
Lamivudine—Deafness—Furosemide—dilated cardiomyopathy	0.00151	0.00801	CcSEcCtD
Lamivudine—ABCC1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00151	0.01	CbGpPWpGaD
Lamivudine—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00151	0.00799	CcSEcCtD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00148	0.00983	CbGpPWpGaD
Lamivudine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00144	0.00763	CcSEcCtD
Lamivudine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00143	0.00759	CcSEcCtD
Lamivudine—Thirst—Furosemide—dilated cardiomyopathy	0.00142	0.00753	CcSEcCtD
Lamivudine—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00142	0.0075	CcSEcCtD
Lamivudine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00139	0.00736	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00137	0.00911	CbGpPWpGaD
Lamivudine—Wheezing—Lisinopril—dilated cardiomyopathy	0.00136	0.00719	CcSEcCtD
Lamivudine—Malaise—Spironolactone—dilated cardiomyopathy	0.00135	0.00715	CcSEcCtD
Lamivudine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00134	0.0071	CcSEcCtD
Lamivudine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00131	0.00696	CcSEcCtD
Lamivudine—Photophobia—Lisinopril—dilated cardiomyopathy	0.00131	0.00696	CcSEcCtD
Lamivudine—DCK—Purine metabolism—GPX1—dilated cardiomyopathy	0.00128	0.00849	CbGpPWpGaD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—RAC1—dilated cardiomyopathy	0.00127	0.00841	CbGpPWpGaD
Lamivudine—DCK—heart—dilated cardiomyopathy	0.00127	0.0367	CbGeAlD
Lamivudine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00126	0.00667	CcSEcCtD
Lamivudine—Dehydration—Furosemide—dilated cardiomyopathy	0.00126	0.00666	CcSEcCtD
Lamivudine—NME2—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.00124	0.0082	CbGpPWpGaD
Lamivudine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00123	0.00653	CcSEcCtD
Lamivudine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00122	0.00647	CcSEcCtD
Lamivudine—ABCC1—myocardium—dilated cardiomyopathy	0.00122	0.0354	CbGeAlD
Lamivudine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00122	0.00645	CcSEcCtD
Lamivudine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0012	0.00634	CcSEcCtD
Lamivudine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00119	0.00632	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00119	0.00792	CbGpPWpGaD
Lamivudine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00118	0.00624	CcSEcCtD
Lamivudine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00117	0.00621	CcSEcCtD
Lamivudine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00115	0.00607	CcSEcCtD
Lamivudine—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00115	0.00607	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00112	0.00745	CbGpPWpGaD
Lamivudine—Injury—Lisinopril—dilated cardiomyopathy	0.00111	0.00585	CcSEcCtD
Lamivudine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00109	0.00576	CcSEcCtD
Lamivudine—DCK—cardiac atrium—dilated cardiomyopathy	0.00108	0.0314	CbGeAlD
Lamivudine—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00108	0.00572	CcSEcCtD
Lamivudine—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00107	0.00565	CcSEcCtD
Lamivudine—ABCC4—Platelet degranulation—TTN—dilated cardiomyopathy	0.00106	0.00703	CbGpPWpGaD
Lamivudine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00106	0.00559	CcSEcCtD
Lamivudine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00106	0.00559	CcSEcCtD
Lamivudine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00104	0.00551	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00103	0.00548	CcSEcCtD
Lamivudine—Renal failure—Furosemide—dilated cardiomyopathy	0.00103	0.00543	CcSEcCtD
Lamivudine—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00102	0.00679	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00101	0.0067	CbGpPWpGaD
Lamivudine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00101	0.00534	CcSEcCtD
Lamivudine—ABCC4—heart—dilated cardiomyopathy	0.001	0.029	CbGeAlD
Lamivudine—Sweating—Furosemide—dilated cardiomyopathy	0.001	0.00529	CcSEcCtD
Lamivudine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000987	0.00522	CcSEcCtD
Lamivudine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000974	0.00515	CcSEcCtD
Lamivudine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000972	0.00514	CcSEcCtD
Lamivudine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000967	0.00512	CcSEcCtD
Lamivudine—Dehydration—Lisinopril—dilated cardiomyopathy	0.000945	0.005	CcSEcCtD
Lamivudine—NME1—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.000937	0.00622	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000919	0.0061	CbGpPWpGaD
Lamivudine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000915	0.00484	CcSEcCtD
Lamivudine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000908	0.00481	CcSEcCtD
Lamivudine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000901	0.00477	CcSEcCtD
Lamivudine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000885	0.00469	CcSEcCtD
Lamivudine—Influenza—Lisinopril—dilated cardiomyopathy	0.000878	0.00465	CcSEcCtD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000875	0.00581	CbGpPWpGaD
Lamivudine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000865	0.00458	CcSEcCtD
Lamivudine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000861	0.00456	CcSEcCtD
Lamivudine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000855	0.00453	CcSEcCtD
Lamivudine—ABCC1—heart—dilated cardiomyopathy	0.000853	0.0247	CbGeAlD
Lamivudine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000846	0.00448	CcSEcCtD
Lamivudine—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000844	0.00447	CcSEcCtD
Lamivudine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000837	0.00443	CcSEcCtD
Lamivudine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000834	0.00441	CcSEcCtD
Lamivudine—ABCC1—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00083	0.00551	CbGpPWpGaD
Lamivudine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000821	0.00435	CcSEcCtD
Lamivudine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000821	0.00435	CcSEcCtD
Lamivudine—Erythema—Furosemide—dilated cardiomyopathy	0.000815	0.00432	CcSEcCtD
Lamivudine—Malnutrition—Furosemide—dilated cardiomyopathy	0.000815	0.00432	CcSEcCtD
Lamivudine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000809	0.00428	CcSEcCtD
Lamivudine—Flatulence—Furosemide—dilated cardiomyopathy	0.000803	0.00425	CcSEcCtD
Lamivudine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000798	0.00423	CcSEcCtD
Lamivudine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000792	0.00419	CcSEcCtD
Lamivudine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000784	0.00415	CcSEcCtD
Lamivudine—ABCC4—Platelet degranulation—VCL—dilated cardiomyopathy	0.000781	0.00519	CbGpPWpGaD
Lamivudine—Depression—Lisinopril—dilated cardiomyopathy	0.00078	0.00413	CcSEcCtD
Lamivudine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000778	0.00412	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000776	0.00411	CcSEcCtD
Lamivudine—Rash—Spironolactone—dilated cardiomyopathy	0.000771	0.00408	CcSEcCtD
Lamivudine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00077	0.00408	CcSEcCtD
Lamivudine—Renal failure—Lisinopril—dilated cardiomyopathy	0.000769	0.00407	CcSEcCtD
Lamivudine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000769	0.00511	CbGpPWpGaD
Lamivudine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000767	0.00406	CcSEcCtD
Lamivudine—Headache—Spironolactone—dilated cardiomyopathy	0.000766	0.00406	CcSEcCtD
Lamivudine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000763	0.00404	CcSEcCtD
Lamivudine—Anaemia—Furosemide—dilated cardiomyopathy	0.000754	0.00399	CcSEcCtD
Lamivudine—Sweating—Lisinopril—dilated cardiomyopathy	0.00075	0.00397	CcSEcCtD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000744	0.00494	CbGpPWpGaD
Lamivudine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00074	0.00392	CcSEcCtD
Lamivudine—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000738	0.00391	CcSEcCtD
Lamivudine—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000734	0.00389	CcSEcCtD
Lamivudine—Vertigo—Furosemide—dilated cardiomyopathy	0.000732	0.00388	CcSEcCtD
Lamivudine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00073	0.00387	CcSEcCtD
Lamivudine—ABCC1—cardiac atrium—dilated cardiomyopathy	0.00073	0.0211	CbGeAlD
Lamivudine—Leukopenia—Furosemide—dilated cardiomyopathy	0.00073	0.00386	CcSEcCtD
Lamivudine—Nausea—Spironolactone—dilated cardiomyopathy	0.000726	0.00385	CcSEcCtD
Lamivudine—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.00072	0.00478	CbGpPWpGaD
Lamivudine—ABCG2—heart—dilated cardiomyopathy	0.000707	0.0205	CbGeAlD
Lamivudine—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000704	0.00373	CcSEcCtD
Lamivudine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000703	0.00372	CcSEcCtD
Lamivudine—CMPK1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000701	0.00465	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ANKRD1—dilated cardiomyopathy	0.000701	0.00465	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000701	0.00465	CbGpPWpGaD
Lamivudine—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000697	0.00369	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000689	0.00365	CcSEcCtD
Lamivudine—Dry mouth—Furosemide—dilated cardiomyopathy	0.000679	0.00359	CcSEcCtD
Lamivudine—Confusional state—Furosemide—dilated cardiomyopathy	0.000671	0.00355	CcSEcCtD
Lamivudine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000665	0.00352	CcSEcCtD
Lamivudine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000664	0.00352	CcSEcCtD
Lamivudine—PCYT2—Metabolism—TAZ—dilated cardiomyopathy	0.000659	0.00438	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—TAZ—dilated cardiomyopathy	0.000659	0.00438	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—TAZ—dilated cardiomyopathy	0.000659	0.00438	CbGpPWpGaD
Lamivudine—Shock—Furosemide—dilated cardiomyopathy	0.000655	0.00347	CcSEcCtD
Lamivudine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000653	0.00345	CcSEcCtD
Lamivudine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000651	0.00345	CcSEcCtD
Lamivudine—Skin disorder—Furosemide—dilated cardiomyopathy	0.000646	0.00342	CcSEcCtD
Lamivudine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000643	0.00341	CcSEcCtD
Lamivudine—DCK—Nucleotide metabolism—GPX1—dilated cardiomyopathy	0.000642	0.00426	CbGpPWpGaD
Lamivudine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000641	0.00426	CbGpPWpGaD
Lamivudine—Anorexia—Furosemide—dilated cardiomyopathy	0.000634	0.00336	CcSEcCtD
Lamivudine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000633	0.00335	CcSEcCtD
Lamivudine—Chills—Lisinopril—dilated cardiomyopathy	0.00063	0.00334	CcSEcCtD
Lamivudine—Hypotension—Furosemide—dilated cardiomyopathy	0.000622	0.00329	CcSEcCtD
Lamivudine—Alopecia—Lisinopril—dilated cardiomyopathy	0.000621	0.00329	CcSEcCtD
Lamivudine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000612	0.00324	CcSEcCtD
Lamivudine—Erythema—Lisinopril—dilated cardiomyopathy	0.000612	0.00324	CcSEcCtD
Lamivudine—Flatulence—Lisinopril—dilated cardiomyopathy	0.000603	0.00319	CcSEcCtD
Lamivudine—Tension—Lisinopril—dilated cardiomyopathy	0.0006	0.00318	CcSEcCtD
Lamivudine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000599	0.00317	CcSEcCtD
Lamivudine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000598	0.00397	CbGpPWpGaD
Lamivudine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000597	0.00316	CcSEcCtD
Lamivudine—CMPK1—Metabolism—SDHA—dilated cardiomyopathy	0.000596	0.00396	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—SDHA—dilated cardiomyopathy	0.000596	0.00396	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—SDHA—dilated cardiomyopathy	0.000596	0.00396	CbGpPWpGaD
Lamivudine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000594	0.00315	CcSEcCtD
Lamivudine—Back pain—Lisinopril—dilated cardiomyopathy	0.000592	0.00313	CcSEcCtD
Lamivudine—Somnolence—Furosemide—dilated cardiomyopathy	0.000592	0.00313	CcSEcCtD
Lamivudine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000588	0.00311	CcSEcCtD
Lamivudine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000578	0.00306	CcSEcCtD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—dilated cardiomyopathy	0.000576	0.00383	CbGpPWpGaD
Lamivudine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000574	0.00304	CcSEcCtD
Lamivudine—Fatigue—Furosemide—dilated cardiomyopathy	0.000574	0.00304	CcSEcCtD
Lamivudine—Tremor—Lisinopril—dilated cardiomyopathy	0.000573	0.00303	CcSEcCtD
Lamivudine—PGK1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000572	0.00379	CbGpPWpGaD
Lamivudine—Constipation—Furosemide—dilated cardiomyopathy	0.000569	0.00301	CcSEcCtD
Lamivudine—Pain—Furosemide—dilated cardiomyopathy	0.000569	0.00301	CcSEcCtD
Lamivudine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000568	0.003	CcSEcCtD
Lamivudine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000565	0.00299	CcSEcCtD
Lamivudine—Angioedema—Lisinopril—dilated cardiomyopathy	0.000559	0.00296	CcSEcCtD
Lamivudine—Malaise—Lisinopril—dilated cardiomyopathy	0.000552	0.00292	CcSEcCtD
Lamivudine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00055	0.00291	CcSEcCtD
Lamivudine—Syncope—Lisinopril—dilated cardiomyopathy	0.000549	0.0029	CcSEcCtD
Lamivudine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000548	0.0029	CcSEcCtD
Lamivudine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000548	0.0029	CcSEcCtD
Lamivudine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000544	0.00288	CcSEcCtD
Lamivudine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000538	0.00285	CcSEcCtD
Lamivudine—PGK1—Metabolism—TAZ—dilated cardiomyopathy	0.000537	0.00357	CbGpPWpGaD
Lamivudine—Cough—Lisinopril—dilated cardiomyopathy	0.000534	0.00283	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000531	0.00353	CbGpPWpGaD
Lamivudine—Urticaria—Furosemide—dilated cardiomyopathy	0.000529	0.0028	CcSEcCtD
Lamivudine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000526	0.00278	CcSEcCtD
Lamivudine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000526	0.00278	CcSEcCtD
Lamivudine—Chest pain—Lisinopril—dilated cardiomyopathy	0.000521	0.00276	CcSEcCtD
Lamivudine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000521	0.00276	CcSEcCtD
Lamivudine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000521	0.00276	CcSEcCtD
Lamivudine—ABCC4—Ectoderm Differentiation—DMD—dilated cardiomyopathy	0.000519	0.00345	CbGpPWpGaD
Lamivudine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000519	0.00275	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000517	0.00274	CcSEcCtD
Lamivudine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000515	0.00272	CcSEcCtD
Lamivudine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000509	0.0027	CcSEcCtD
Lamivudine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000503	0.00266	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—TAZ—dilated cardiomyopathy	0.0005	0.00332	CbGpPWpGaD
Lamivudine—Oedema—Lisinopril—dilated cardiomyopathy	0.000499	0.00264	CcSEcCtD
Lamivudine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000499	0.00264	CcSEcCtD
Lamivudine—Infection—Lisinopril—dilated cardiomyopathy	0.000496	0.00263	CcSEcCtD
Lamivudine—Shock—Lisinopril—dilated cardiomyopathy	0.000491	0.0026	CcSEcCtD
Lamivudine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00049	0.0026	CcSEcCtD
Lamivudine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000489	0.00259	CcSEcCtD
Lamivudine—PGK1—Metabolism—SDHA—dilated cardiomyopathy	0.000486	0.00323	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000486	0.00323	CbGpPWpGaD
Lamivudine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000485	0.00257	CcSEcCtD
Lamivudine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000483	0.00255	CcSEcCtD
Lamivudine—Asthenia—Furosemide—dilated cardiomyopathy	0.000477	0.00253	CcSEcCtD
Lamivudine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000476	0.00252	CcSEcCtD
Lamivudine—Pruritus—Furosemide—dilated cardiomyopathy	0.000471	0.00249	CcSEcCtD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00047	0.00312	CbGpPWpGaD
Lamivudine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000466	0.00247	CcSEcCtD
Lamivudine—SLC22A3—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000465	0.00308	CbGpPWpGaD
Lamivudine—NME2—Metabolism—TAZ—dilated cardiomyopathy	0.000457	0.00303	CbGpPWpGaD
Lamivudine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000455	0.00241	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000455	0.00241	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—SDHA—dilated cardiomyopathy	0.000452	0.003	CbGpPWpGaD
Lamivudine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000452	0.00239	CcSEcCtD
Lamivudine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000448	0.00237	CcSEcCtD
Lamivudine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000445	0.00236	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000444	0.00295	CbGpPWpGaD
Lamivudine—Somnolence—Lisinopril—dilated cardiomyopathy	0.000444	0.00235	CcSEcCtD
Lamivudine—Dizziness—Furosemide—dilated cardiomyopathy	0.00044	0.00233	CcSEcCtD
Lamivudine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000439	0.00233	CcSEcCtD
Lamivudine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000434	0.0023	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000431	0.00228	CcSEcCtD
Lamivudine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00043	0.00228	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000428	0.00284	CbGpPWpGaD
Lamivudine—Pain—Lisinopril—dilated cardiomyopathy	0.000427	0.00226	CcSEcCtD
Lamivudine—Constipation—Lisinopril—dilated cardiomyopathy	0.000427	0.00226	CcSEcCtD
Lamivudine—Vomiting—Furosemide—dilated cardiomyopathy	0.000423	0.00224	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00042	0.00279	CbGpPWpGaD
Lamivudine—Rash—Furosemide—dilated cardiomyopathy	0.00042	0.00222	CcSEcCtD
Lamivudine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000419	0.00222	CcSEcCtD
Lamivudine—ABCC1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000417	0.00277	CbGpPWpGaD
Lamivudine—Headache—Furosemide—dilated cardiomyopathy	0.000417	0.00221	CcSEcCtD
Lamivudine—NME2—Metabolism—SDHA—dilated cardiomyopathy	0.000413	0.00274	CbGpPWpGaD
Lamivudine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000411	0.00218	CcSEcCtD
Lamivudine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000408	0.00216	CcSEcCtD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000408	0.00271	CbGpPWpGaD
Lamivudine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000397	0.0021	CcSEcCtD
Lamivudine—Nausea—Furosemide—dilated cardiomyopathy	0.000395	0.00209	CcSEcCtD
Lamivudine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000395	0.00209	CcSEcCtD
Lamivudine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000395	0.00209	CcSEcCtD
Lamivudine—NME1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000368	0.00245	CbGpPWpGaD
Lamivudine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000368	0.00195	CcSEcCtD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000364	0.00241	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—RAF1—dilated cardiomyopathy	0.000358	0.00238	CbGpPWpGaD
Lamivudine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000358	0.0019	CcSEcCtD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000354	0.00235	CbGpPWpGaD
Lamivudine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000353	0.00187	CcSEcCtD
Lamivudine—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00035	0.00232	CbGpPWpGaD
Lamivudine—ABCB1—heart—dilated cardiomyopathy	0.000348	0.0101	CbGeAlD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000347	0.0023	CbGpPWpGaD
Lamivudine—NME1—Metabolism—TAZ—dilated cardiomyopathy	0.000346	0.0023	CbGpPWpGaD
Lamivudine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000342	0.00181	CcSEcCtD
Lamivudine—ABCC4—Platelet degranulation—CD36—dilated cardiomyopathy	0.000335	0.00222	CbGpPWpGaD
Lamivudine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00033	0.00175	CcSEcCtD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000329	0.00219	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00032	0.00213	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000319	0.00212	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000319	0.00212	CbGpPWpGaD
Lamivudine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000317	0.00168	CcSEcCtD
Lamivudine—Rash—Lisinopril—dilated cardiomyopathy	0.000315	0.00167	CcSEcCtD
Lamivudine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000314	0.00166	CcSEcCtD
Lamivudine—NME1—Metabolism—SDHA—dilated cardiomyopathy	0.000313	0.00208	CbGpPWpGaD
Lamivudine—Headache—Lisinopril—dilated cardiomyopathy	0.000313	0.00166	CcSEcCtD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00031	0.00206	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000299	0.00198	CbGpPWpGaD
Lamivudine—PGK1—Disease—NPPA—dilated cardiomyopathy	0.000297	0.00197	CbGpPWpGaD
Lamivudine—Nausea—Lisinopril—dilated cardiomyopathy	0.000297	0.00157	CcSEcCtD
Lamivudine—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000291	0.00193	CbGpPWpGaD
Lamivudine—PGK1—Disease—PSEN2—dilated cardiomyopathy	0.000288	0.00191	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000278	0.00185	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000276	0.00183	CbGpPWpGaD
Lamivudine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000272	0.0018	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000268	0.00178	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000258	0.00171	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000256	0.0017	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ANKRD1—dilated cardiomyopathy	0.000253	0.00168	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000245	0.00163	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000243	0.00161	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000243	0.00161	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TTN—dilated cardiomyopathy	0.000242	0.00161	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000242	0.0016	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000239	0.00158	CbGpPWpGaD
Lamivudine—DCK—Metabolism—TAZ—dilated cardiomyopathy	0.000238	0.00158	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000236	0.00157	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000236	0.00157	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000229	0.00152	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000223	0.00148	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00022	0.00146	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000217	0.00144	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000217	0.00144	CbGpPWpGaD
Lamivudine—DCK—Metabolism—SDHA—dilated cardiomyopathy	0.000215	0.00143	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	0.00021	0.00139	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00021	0.00139	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000204	0.00135	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000204	0.00135	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000204	0.00135	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000202	0.00134	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000191	0.00127	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00019	0.00126	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000183	0.00121	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000182	0.00121	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	0.000179	0.00119	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000178	0.00118	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000178	0.00118	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000177	0.00117	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000175	0.00116	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000172	0.00114	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000172	0.00114	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000171	0.00114	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00017	0.00113	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00017	0.00113	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000165	0.0011	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—GPX1—dilated cardiomyopathy	0.000162	0.00108	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—GPX1—dilated cardiomyopathy	0.000162	0.00108	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—GPX1—dilated cardiomyopathy	0.000162	0.00108	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00016	0.00106	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00016	0.00106	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000158	0.00105	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—CD36—dilated cardiomyopathy	0.000158	0.00105	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CD36—dilated cardiomyopathy	0.000158	0.00105	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—CD36—dilated cardiomyopathy	0.000158	0.00105	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000154	0.00102	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000152	0.00101	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TAZ—dilated cardiomyopathy	0.00015	0.000996	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00015	0.000993	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00015	0.000993	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000148	0.000985	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000148	0.000983	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000148	0.000983	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000147	0.000973	CbGpPWpGaD
Lamivudine—PGK1—Disease—RAC1—dilated cardiomyopathy	0.000145	0.00096	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000144	0.000954	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—AGT—dilated cardiomyopathy	0.000142	0.000943	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—AGT—dilated cardiomyopathy	0.000142	0.000943	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—AGT—dilated cardiomyopathy	0.000142	0.000943	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000142	0.000942	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00014	0.000928	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000139	0.000923	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000138	0.000916	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000138	0.000916	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	0.000138	0.000915	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000138	0.000914	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—SDHA—dilated cardiomyopathy	0.000136	0.0009	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000134	0.000887	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—GPX1—dilated cardiomyopathy	0.000132	0.000876	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000129	0.000855	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—CD36—dilated cardiomyopathy	0.000129	0.000854	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000128	0.000852	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	0.000125	0.000828	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—GPX1—dilated cardiomyopathy	0.000123	0.000815	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—CD36—dilated cardiomyopathy	0.00012	0.000794	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—AGT—dilated cardiomyopathy	0.000116	0.000769	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000115	0.000763	CbGpPWpGaD
Lamivudine—NME2—Metabolism—GPX1—dilated cardiomyopathy	0.000112	0.000745	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CD36—dilated cardiomyopathy	0.000109	0.000726	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	0.000108	0.000717	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—AGT—dilated cardiomyopathy	0.000108	0.000714	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000101	0.000671	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.0001	0.000664	CbGpPWpGaD
Lamivudine—NME2—Metabolism—AGT—dilated cardiomyopathy	9.84e-05	0.000653	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	9.77e-05	0.000649	CbGpPWpGaD
Lamivudine—PGK1—Disease—RAF1—dilated cardiomyopathy	9.59e-05	0.000637	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	9.51e-05	0.000631	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	9.41e-05	0.000625	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	9.33e-05	0.000619	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	9.27e-05	0.000616	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	8.97e-05	0.000595	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	8.77e-05	0.000582	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	8.6e-05	0.000571	CbGpPWpGaD
Lamivudine—NME1—Metabolism—GPX1—dilated cardiomyopathy	8.51e-05	0.000565	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	8.51e-05	0.000565	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.32e-05	0.000552	CbGpPWpGaD
Lamivudine—NME1—Metabolism—CD36—dilated cardiomyopathy	8.29e-05	0.00055	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.09e-05	0.000537	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.09e-05	0.000537	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	7.93e-05	0.000526	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	7.65e-05	0.000508	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.61e-05	0.000505	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.52e-05	0.000499	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AGT—dilated cardiomyopathy	7.46e-05	0.000495	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.41e-05	0.000492	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.29e-05	0.000484	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	7.21e-05	0.000479	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	6.79e-05	0.000451	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.67e-05	0.000443	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.59e-05	0.000438	CbGpPWpGaD
Lamivudine—PGK1—Disease—EGFR—dilated cardiomyopathy	6.58e-05	0.000437	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	6.36e-05	0.000422	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	6.23e-05	0.000414	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NPPA—dilated cardiomyopathy	5.97e-05	0.000396	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.96e-05	0.000396	CbGpPWpGaD
Lamivudine—DCK—Metabolism—GPX1—dilated cardiomyopathy	5.84e-05	0.000387	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.8e-05	0.000385	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PSEN2—dilated cardiomyopathy	5.78e-05	0.000384	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CD36—dilated cardiomyopathy	5.68e-05	0.000377	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	5.59e-05	0.000371	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	5.47e-05	0.000363	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	5.47e-05	0.000363	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.23e-05	0.000347	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	5.21e-05	0.000346	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	5.14e-05	0.000341	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AGT—dilated cardiomyopathy	5.12e-05	0.00034	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.79e-05	0.000318	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	4.78e-05	0.000317	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	4.65e-05	0.000309	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.4e-05	0.000292	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.14e-05	0.000275	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.13e-05	0.000274	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GPX1—dilated cardiomyopathy	3.69e-05	0.000245	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.6e-05	0.000239	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CD36—dilated cardiomyopathy	3.59e-05	0.000238	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.49e-05	0.000232	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.45e-05	0.000229	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	3.39e-05	0.000225	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CD36—dilated cardiomyopathy	3.3e-05	0.000219	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AGT—dilated cardiomyopathy	3.23e-05	0.000214	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.03e-05	0.000201	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3e-05	0.000199	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AGT—dilated cardiomyopathy	2.97e-05	0.000197	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAC1—dilated cardiomyopathy	2.91e-05	0.000193	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.83e-05	0.000188	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.8e-05	0.000186	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.7e-05	0.000179	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	2.65e-05	0.000176	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CD36—dilated cardiomyopathy	2.58e-05	0.000172	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	2.34e-05	0.000155	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AGT—dilated cardiomyopathy	2.33e-05	0.000154	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	2.31e-05	0.000153	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CD36—dilated cardiomyopathy	2.27e-05	0.000151	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	2.25e-05	0.000149	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	2.15e-05	0.000143	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	2.1e-05	0.000139	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AGT—dilated cardiomyopathy	2.05e-05	0.000136	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	2.03e-05	0.000135	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAF1—dilated cardiomyopathy	1.93e-05	0.000128	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	1.89e-05	0.000125	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.64e-05	0.000109	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—dilated cardiomyopathy	1.32e-05	8.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.26e-05	8.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.23e-05	8.16e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1.11e-05	7.35e-05	CbGpPWpGaD
